Diabetes Care

Papers
(The H4-Index of Diabetes Care is 84. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—20211678
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—20221102
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021710
Social Determinants of Health and Diabetes: A Scientific Review624
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023624
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021544
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022499
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)481
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China427
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023376
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022375
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021332
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?320
Obesity Is a Risk Factor for Greater COVID-19 Severity300
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication296
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study290
New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.285
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022260
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)249
6. Glycemic Targets: Standards of Care in Diabetes—2023233
Introduction: Standards of Medical Care in Diabetes—2022228
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021218
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)211
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2021210
Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, th198
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Stud192
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes192
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023180
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening177
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)177
COVID-19, Hyperglycemia, and New-Onset Diabetes165
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2022164
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?160
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021160
Introduction: Standards of Medical Care in Diabetes—2021159
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study158
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021158
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-155
A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison153
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes151
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022149
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspe148
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022148
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023143
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021143
Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters139
Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?137
12. Older Adults:Standards of Medical Care in Diabetes—2021136
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes131
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021131
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study128
Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers127
7. Diabetes Technology: Standards of Care in Diabetes—2023126
15. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2022126
Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015125
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021124
Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study124
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—2022123
Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020122
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association121
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023116
Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study116
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022116
Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study113
13. Older Adults: Standards of Medical Care in Diabetes—2022113
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy110
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit109
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.107
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes105
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021102
8. Obesity Management for the Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021101
14. Children and Adolescents: Standards of Medical Care in Diabetes—2022100
Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People100
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?99
Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis96
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—202394
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial93
Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes93
Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes93
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)92
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—202292
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies91
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—202391
Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes84
Association of a Healthy Lifestyle With All-Cause and Cause-Specific Mortality Among Individuals With Type 2 Diabetes: A Prospective Study in UK Biobank84
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes—202284
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial84
0.030116081237793